Search research articles
Contact Us
Filters
Showing results (1-10 of 155) with videos related to
Page
of 16
Sort By:
F1000 Biology Reports
|
October 18, 2011
Adenosine receptors and fibrosis: a translational review
Bruce N Cronstein
Arthritis Research & Therapy
|
August 26, 2010
A personal journey from the joint to the heart
Bruce N Cronstein
Pharmacological Reviews
|
May 26, 2005
Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis
Bruce N Cronstein
Arthritis and Rheumatism
|
April 9, 2005
Folic acid and folinic acid supplements and methotrexate therapy: comment on the article by Morgan et al
Bruce N Cronstein
Nature Clinical Practice. Rheumatology
|
August 26, 2006
Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture
Bruce N Cronstein
Nature Clinical Practice. Rheumatology
|
March 22, 2007
Do elevated red blood cell methotrexate polyglutamate levels predict methotrexate efficacy?
Bruce N Cronstein
Bulletin of the NYU Hospital for Joint Diseases
|
November 24, 2006
Pharmacogenetics in the rheumatic diseases
Bruce N Cronstein
Bulletin of the NYU Hospital for Joint Diseases
|
October 10, 2007
Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis
Bruce N Cronstein
Nature Clinical Practice. Rheumatology
|
November 30, 2006
Do genetic variations in the adenosine pathway affect patient response to methotrexate?
Bruce N Cronstein
Cleveland Clinic Journal of Medicine
|
June 28, 2002
Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility
Bruce N Cronstein
Page
of 16
Search research articles
Search
Showing results (1-10 of 155) with videos related to
Sort By:
Page
of 16
F1000 Biology Reports
|
October 18, 2011
Adenosine receptors and fibrosis: a translational review
Bruce N Cronstein
Arthritis Research & Therapy
|
August 26, 2010
A personal journey from the joint to the heart
Bruce N Cronstein
Pharmacological Reviews
|
May 26, 2005
Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis
Bruce N Cronstein
Arthritis and Rheumatism
|
April 9, 2005
Folic acid and folinic acid supplements and methotrexate therapy: comment on the article by Morgan et al
Bruce N Cronstein
Nature Clinical Practice. Rheumatology
|
August 26, 2006
Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture
Bruce N Cronstein
Nature Clinical Practice. Rheumatology
|
March 22, 2007
Do elevated red blood cell methotrexate polyglutamate levels predict methotrexate efficacy?
Bruce N Cronstein
Bulletin of the NYU Hospital for Joint Diseases
|
November 24, 2006
Pharmacogenetics in the rheumatic diseases
Bruce N Cronstein
Bulletin of the NYU Hospital for Joint Diseases
|
October 10, 2007
Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis
Bruce N Cronstein
Nature Clinical Practice. Rheumatology
|
November 30, 2006
Do genetic variations in the adenosine pathway affect patient response to methotrexate?
Bruce N Cronstein
Cleveland Clinic Journal of Medicine
|
June 28, 2002
Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility
Bruce N Cronstein
Page
of 16